Cdk5 drives formation of heterogeneous pancreatic neuroendocrine tumors
A. M. Carter, N. Kumar, B. Herring, C. Tan, R. Guenter, R. Telange, W. Howse, F. Viol, C. Graham, T. R. McCaw, h. Bickerton, F. Gillardon, E. A. Woltering, J. Totenhagen, R. Banerjee, , J. Bibb
This paper develops a mouse model of PanNETs driven by Cdk5 and shows its relevance to human tumors, supporting Cdk5 as a therapeutic target.
bioRxiv · May 25, 2021Cancer Biology